LCG
CVS icon

Lynx Capital Group’s CVS Health CVS Stock Holding History

Lynx Capital Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-28,544
Closed -$2.28M – 80
2024
Q1 		$2.28M Buy
28,544
+3,745
+15% +$286K 1.54% 35
2023
Q4 		$1.96M Buy
+24,799
New +$1.76M 1.43% 37

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Lynx Capital Group's CVS Position: Q2 2024 in Review

Lynx Capital Group sold out of CVS Health (CVS) in Q2 2024, closing a stake of 28,544 shares — an estimated $2.28M sold.

Lynx Capital Group first reported a position in CVS in Q4 2023 and held it in 2 quarters. The position peaked at $2.28M in Q1 2024. 1,913 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Lynx Capital Group reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Lynx Capital Group sold 28,544 CVS Health shares in Q2 2024, an estimated $2.28M.
  • Lynx Capital Group first reported a position in CVS Health in Q4 2023 and held it in 2 quarters.
  • Lynx Capital Group's CVS Health position peaked at $2.28M in Q1 2024.
  • 1,913 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Lynx Capital Group's 13F filing for Q2 2024, filed 10 Aug 2026.